Merck Seeks Emergency Use Authorization for Pill for Covid

Merck and partner Ridgeback Biotherapeutics sought emergency use authorization in the U.S. for molnupiravir, moving the pill closer to becoming the first oral antiviral Covid treatment. Bloomberg